Scilex Holding (SCLX) Amortization of Deferred Charges (2020 - 2026)
Scilex Holding (SCLX) posted quarterly Amortization of Deferred Charges of $1.0 million for Q1 2026, up 151.34% quarter-over-quarter from $409000.0 in Q4 2025.
Scilex Holding (SCLX) Amortization of Deferred Charges (2020 - 2026) Analysis & Trends
Scilex Holding's Amortization of Deferred Charges history runs 6 years deep, the most recent figure standing at $1.0 million for Q1 2026.
- In Q1 2026, Amortization of Deferred Charges changed N/A year-over-year to $1.0 million; the TTM figure through Mar 2026 stood at $1.4 million (up 404.21% YoY), while the FY2025 annual figure was $409000.0, up 29.43% from the prior year.
- Amortization of Deferred Charges for Q1 2026 stood at $1.0 million, up from $409000.0 in the prior quarter.
- The five-year high for Amortization of Deferred Charges was $1.9 million in Q1 2022, with the low at $1000.0 in Q2 2023.
- The 5-year median for Amortization of Deferred Charges is $34000.0 (2022), against an average of $381538.5.
- The sharpest annual moves came in 2023 and 2024: Amortization of Deferred Charges sank 99.92% in 2023, then jumped 3100.0% in 2024.
- Scilex Holding's Amortization of Deferred Charges stood at $34000.0 in 2022, then fell by 8.82% to $31000.0 in 2023, then surged by 616.13% to $222000.0 in 2024, then jumped by 84.23% to $409000.0 in 2025, then surged by 151.34% to $1.0 million in 2026.
- Business Quant data shows SCLX's Amortization of Deferred Charges at $1.0 million in Q1 2026, $409000.0 in Q4 2025, and $222000.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn |
| 10 | Scilex Holding | 39.22 Mn | -73.57 Mn | 3.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.03 Mn |
| Mar 31, 2026 | 1.03 Mn |
| Dec 31, 2025 | 409,000.00 |
| Dec 31, 2025 | 409,000.00 |
| Dec 31, 2024 | 222,000.00 |
| Dec 31, 2024 | 222,000.00 |
| Sep 30, 2024 | 31,000.00 |
| Sep 30, 2024 | 31,000.00 |
| Jun 30, 2024 | 32,000.00 |
| Jun 30, 2024 | 32,000.00 |
| Mar 31, 2024 | 31,000.00 |
| Mar 31, 2024 | 31,000.00 |
| Dec 31, 2023 | 31,000.00 |
| Dec 31, 2023 | 31,000.00 |
| Sep 30, 2023 | 33,000.00 |
| Sep 30, 2023 | 33,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Dec 31, 2022 | 34,000.00 |
| Dec 31, 2022 | 34,000.00 |